ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,396Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 939

$747K Total Retail Price of All Prescriptions

Rank: 107 out of 939

393 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 717 405 S3 1 1
LEVOTHYROXINE SODIUM 534 401 2 4
LISINOPRIL 490 325 3 3
OMEPRAZOLE 455 298 4 5
AMLODIPINE BESYLATE 372 344 5 6
CITALOPRAM HBR 363 267 6 15
FUROSEMIDE 328 207 7 7
SIMVASTATIN 296 261 8 2
TRAZODONE HCL 282 139 9 26
GABAPENTIN 274 160 10 11
ZOLPIDEM TARTRATE 249 167 11 20
METFORMIN HCL 249 128 11 8
MELOXICAM 232 147 13 14
POTASSIUM CHLORIDE 215 140 14 9
ATENOLOL 180 102 15 19
TRAMADOL HCL 161 105 16 16
PRAVASTATIN SODIUM 156 138 17 13
NEXIUM 155 98 18 18
ATORVASTATIN CALCIUM 140 116 19 22
CYCLOBENZAPRINE HCL 138 43 R 20 36
METOPROLOL TARTRATE 134 112 21 10
MIRTAZAPINE 134 122 21 56
CYMBALTA 132 25 23 44
CARVEDILOL 126 99 24 25
FLUOXETINE HCL 125 56 25 47
FLUCONAZOLE 125 65 25 140
HYDROCHLOROTHIAZIDE 112 106 27 12
GLIPIZIDE 111 46 28 52
LYRICA 108 65 29 63
CARISOPRODOL 107 0 R 30 51
FLUTICASONE PROPIONATE 104 79 31 43
AZITHROMYCIN 99 62 32 32
TRIAMTERENE-HCTZ 98 71 33 33
CLOPIDOGREL 91 67 34 28
ADVAIR DISKUS 89 28 35 60
VENLAFAXINE HCL ER 87 57 36 121
RANITIDINE HCL 85 55 37 35
LOSARTAN POTASSIUM 85 71 37 29
TAMSULOSIN HCL 84 74 39 27
AMITRIPTYLINE HCL 78 36 R 40 38
POLYETHYLENE GLYCOL 3350 75 25 41 57
DONEPEZIL HCL 74 66 42 30
FAMOTIDINE 72 56 43 62
WARFARIN SODIUM 72 56 43 17
BUSPIRONE HCL 71 44 45 123
VENTOLIN HFA 70 26 46 80
PROAIR HFA 68 26 47 41
ROPINIROLE HCL 66 40 48 78
BUPROPION XL 66 46 48 179
EXFORGE 66 59 48 176
PREDNISONE 65 33 51 42
CIPROFLOXACIN HCL 65 53 51 54
TIZANIDINE HCL 65 39 51 81
PROPRANOLOL HCL 64 49 54 117
ESTRADIOL 61 41 R 55 79
SERTRALINE HCL 60 17 56 24
LANTUS SOLOSTAR 59 31 57 128
CEFDINIR 59 34 57 142
CLONIDINE HCL 58 45 59 39
LEVOFLOXACIN 58 25 59 86
KLOR-CON M20 56 45 61 90
PLAVIX 55 42 62 48
METOPROLOL SUCCINATE 54 29 63 21
SPIRIVA 54 42 63 73
ENALAPRIL MALEATE 52 37 65 65
FENOFIBRATE 50 43 66 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.